Antimicrobial peptides: therapeutic potential

Bibliography

• REDDY KV, YEDERY RD, ARANHA C: Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents (2004) 24(6):536-547.
   PubMed Web of Science ®Google Scholar
• TOKE O: Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers (2005) 80(6):717-735.
   PubMed Web of Science ®Google Scholar
• OTVOS L Jr: Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci. (2005) 11(11):697-706.
   PubMed Web of Science ®Google Scholar
• ZHANG L, PARENTE J, HARRIS SM et al.: Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. (2005) 49(7):2921-2927.
   PubMed Web of Science ®Google Scholar
• ZHANG L, FALLA TJ: Cationic antimicrobial peptides – an update. Expert Opin. Investig. Drugs (2004) 13(2):97-106.
   PubMedGoogle Scholar
• SELSTED ME, OUELLETTE AJ: Mammalian defensins in the antimicrobial immune response. Nat. Immunol. (2005) 6(6):551-557.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER JJ, UNHOLZER A, SCHALLER M, SCHAFER-KORTING M, KORTING HC: Human defensins. J. Mol. Med. (2005) 83(8):587-595.
   PubMed Web of Science ®Google Scholar
• PATIL A, HUGHES AL, ZHANG G: Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics (2004) 20(1):1-11.
   PubMed Web of Science ®Google Scholar
• RADHAKRISHNAN Y, HAMIL KG, YENUGU S et al.: Identification, characterisation, and evolution of a primate β-defensin gene cluster. Genes Immun. (2005) 6(3):203-210.
   PubMedGoogle Scholar
• NGUYEN TX, COLE AM, LEHRER RI: Evolution of primate θ-defensins: a serpentine path to a sweet tooth. Peptides (2003) 24(11):1647-1654.
   PubMed Web of Science ®Google Scholar
• COLE AM, HONG T, BOO LM et al.: Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc. Natl. Acad. Sci. USA (2002) 99(4):1813-1818.
   PubMed Web of Science ®Google Scholar
• ZANETTI M, GENNARO R, ROMEO D: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. (1995) 374(1):1-5.
   PubMed Web of Science ®Google Scholar
• NIZET V, GALLO RL: Cathelicidins and innate defence against invasive bacterial infection. Scand. J. Infect. Dis. (2003) 35(9):670-676.
   PubMed Web of Science ®Google Scholar
• PARK CH, VALORE EV, WARING AJ, GANZ T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. (2001) 276(11):7806-7810.
   PubMed Web of Science ®Google Scholar
• RIEG S, GARBE C, SAUER B, KALBACHER H, SCHITTEK B: Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br. J. Dermatol. (2004) 151(3):534-539.
   PubMed Web of Science ®Google Scholar
• OPPENHEIM FG, XU T, MCMILLIAN FM et al.: Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. (1988) 263(16):7472-7477.
   PubMed Web of Science ®Google Scholar
• GORDON YJ, HUANG LC, ROMANOWSKI EG et al.: Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res. (2005) 30(5):385-394.
   PubMed Web of Science ®Google Scholar
• MCINTOSH RS, CADE JE, AL-ABED M et al.: The spectrum of antimicrobial peptide expression at the ocular surface. Invest. Ophthalmol. Vis. Sci. (2005) 46(4):1379-1385.
   PubMed Web of Science ®Google Scholar
• BERGMAN P, TERMEN S, JOHANSSON L et al.: The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J. Neurochem. (2005) 93(5):1132-1140.
   PubMedGoogle Scholar
• FLAD T, BOGUMIL R, TOLSON J et al.: Detection of dermcidin-derived peptides in sweat by ProteinChip technology. J. Immunol. Methods (2002) 270(1):53-62.
   PubMedGoogle Scholar
• BARDAN A, NIZET V, GALLO RL: Antimicrobial peptides and the skin. Expert Opin. Biol. Ther. (2004) 4(4):543-549.
   PubMed Web of Science ®Google Scholar
• SORENSEN OE, THAPA DR, ROSENTHAL A et al.: Differential regulation of β-defensin expression in human skin by microbial stimuli. J. Immunol. (2005) 174(8):4870-4879.
   PubMed Web of Science ®Google Scholar
• CHEN X, NIYONSABA F, USHIO H et al.: Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. (2005) 40(2):123-132.
   PubMed Web of Science ®Google Scholar
• LOPEZ-GARCIA B, LEE PH, YAMASAKI K, GALLO RL: Antifungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. (2005) 125(1):108-115.
   PubMed Web of Science ®Google Scholar
• NIZET V, OHTAKE T, LAUTH X et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 414(6862):454-457.
   PubMed Web of Science ®Google Scholar
• LEE PH, OHTAKE T, ZAIOU M et al.: Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. USA (2005) 102(10):3750-3755.
   PubMedGoogle Scholar
• RIEG S, STEFFEN H, SEEBER S et al.: Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defence of human skin in vivo. J. Immunol. (2005) 174(12):8003-8010.
   PubMed Web of Science ®Google Scholar
• HOWELL MD, JONES JF, KISICH KO et al.: Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. (2004) 172(3):1763-1767.
   PubMed Web of Science ®Google Scholar
• MCINTURFF JE, WANG SJ, MACHLEIDT T et al.: Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J. Invest. Dermatol. (2005) 125(2):256-263.
   PubMedGoogle Scholar
• STEINSTRAESSER L, KLEIN RD, AMINLARI A et al.: Protegrin-1 enhances bacterial killing in thermally injured skin. Crit. Care Med. (2001) 29(7):1431-1437.
   PubMed Web of Science ®Google Scholar
• CHALEKSON CP, NEUMEISTER MW, JAYNES J: Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plast. Reconstr. Surg. (2002) 109(4):1338-1343.
   PubMed Web of Science ®Google Scholar
• CARRETERO M, DEL RIO M, GARCIA M et al.: A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J. (2004) 18(15):1931-1933.
   PubMed Web of Science ®Google Scholar
• MANGONI ML, SAUGAR JM, DELLISANTI M et al.: Temporins, small antimicrobial peptides with leishmanicidal activity. J. Biol. Chem. (2005) 280(2):984-990.
   PubMed Web of Science ®Google Scholar
• ALBEROLA J, RODRIGUEZ A, FRANCINO O et al.: Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob. Agents Chemother. (2004) 48(2):641-643.
   PubMed Web of Science ®Google Scholar
• DALE BA, FREDERICKS LP: Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr. Issuets. Mol. Biol. (2005) 7(2):119-133.
   PubMed Web of Science ®Google Scholar
• VANKEERBERGHEN A, NUYTTEN H, DIERICKX K et al.: Differential induction of human β-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J. Periodontol. (2005) 76(8):1293-1303.
   PubMed Web of Science ®Google Scholar
• OUHARA K, KOMATSUZAWA H, YAMADA S et al.: Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. J. Antimicrob. Chemother. (2005) 55(6):888-896.
   PubMed Web of Science ®Google Scholar
• TAO R, JUREVIC RJ, COULTON KK et al.: Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob. Agents Chemother. (2005) 49(9):3883-3888.
   PubMed Web of Science ®Google Scholar
• TANIDA T, OKAMOTO T, OKAMOTO A et al.: Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J. Oral Pathol. Med. (2003) 32(10):586-594.
   PubMedGoogle Scholar
• MEYER JE, HARDER J, GOROGH T et al.: Human β-defensin-2 in oral cancer with opportunistic Candida infection. Anti-Cancer Res. (2004) 24(2B):1025-1030.
   PubMed Web of Science ®Google Scholar
• PUTSEP K, CARLSSON G, BOMAN HG, ANDERSSON M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet (2002) 360(9340):1144-1149.
   PubMed Web of Science ®Google Scholar
• GILES FJ, RODRIGUEZ R, WEISDORF D et al.: A Phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leuk. Res. (2004) 28(6):559-565.
   PubMed Web of Science ®Google Scholar
• PAQUETTE DW, SIMPSON DM, FRIDEN P, BRAMAN V, WILLIAMS RC: Safety and clinical effects of topical histatin gels in humans with experimental gingivitis. J. Clin. Periodontol. (2002) 29(12):1051-1058.
   PubMed Web of Science ®Google Scholar
• PAQUETTE DW, WATERS GS, STEFANIDOU VL et al.: Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. J. Clin. Periodontol. (1997) 24(4):216-222.
   PubMed Web of Science ®Google Scholar
• YOSHINARI M, KATO T, MATSUZAKA K et al.: Adsorption behavior of antimicrobial peptide histatin 5 on PMMA. J. Biomed. Mater. Res. B Appl. Biomater. (2005) 77B(1):47-54.
   Google Scholar
• ASHITANI J, MUKAE H, ARIMURA Y et al.: High concentrations of α-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Life Sci. (2004) 75(9):1123-1134.
   PubMedGoogle Scholar
• ROSS DJ, COLE AM, YOSHIOKA D et al.: Increased bronchoalveolar lavage human β-defensin Type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation (2004) 78(8):1222-1224.
   PubMedGoogle Scholar
• SHELLITO JE: Failure of host defences in human immunodeficiency virus. Semin. Respir. Crit. Care Med. (2004) 25(1):73-84.
   PubMed Web of Science ®Google Scholar
• BALS R, WANG X, WU Z et al.: Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. (1998) 102(5):874-880.
   PubMed Web of Science ®Google Scholar
• BALS R, WEINER DJ, MOSCIONI AD, MEEGALLA RL, WILSON JM: Augmentation of innate host defence by expression of a cathelicidin antimicrobial peptide. Infect. Immun. (1999) 67(11):6084-6089.
   PubMed Web of Science ®Google Scholar
• MYGIND PH, FISCHER RL, SCHNORR KM et al.: Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 437(7061):975-980.
   PubMed Web of Science ®Google Scholar
• WESTERMAN EM, LE BRUN PP, TOUW DJ, FRIJLINK HW, HEIJERMAN HG: Effect of nebulized colistin sulfate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study. J. Cyst. Fibros. (2004) 3(1):23-28.
   PubMedGoogle Scholar
• OUELLETTE AJ: Defensin-mediated innate immunity in the small intestine. Best Pract Res. Clin. Gastroenterol. (2004) 18(2):405-419.
   PubMed Web of Science ®Google Scholar
• VORA P, YOUDIM A, THOMAS LS et al.: β-defensin-2 expression is regulated by TLR signalling in intestinal epithelial cells. J. Immunol. (2004) 173(9):5398-5405.
   PubMed Web of Science ®Google Scholar
• ISOMOTO H, MUKAE H, ISHIMOTO H et al.: High concentrations of human β-defensin 2 in gastric juice of patients with Helicobacter pylori infection. World J. Gastroenterol. (2005) 11(31):4782-4787.
   PubMedGoogle Scholar
• WEHKAMP J, SALZMAN NH, PORTER E et al.: Reduced Paneth cell α-defensins in ileal Crohn’s disease. Proc. Natl. Acad. Sci. USA (2005) 102(50):18129-18134.
   PubMed Web of Science ®Google Scholar
• ECKMANN L: Defence molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. (2005) 21(2):147-151.
   PubMedGoogle Scholar
• IIMURA M, GALLO RL, HASE K et al.: Cathelicidin mediates innate intestinal defence against colonization with epithelial adherent bacterial pathogens. J. Immunol. (2005) 174(8):4901-4907.
   PubMed Web of Science ®Google Scholar
• SALZMAN NH, GHOSH D, HUTTNER KM, PATERSON Y, BEVINS CL: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422(6931):522-526.
   PubMed Web of Science ®Google Scholar
• WIRA CR, FAHEY JV, SENTMAN CL, PIOLI PA, SHEN L: Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. (2005) 206:306-335.
   PubMed Web of Science ®Google Scholar
• JOHN M, KELLER MJ, FAM EH et al.: Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J. Infect. Dis. (2005) 192(10):1731-1740.
   PubMed Web of Science ®Google Scholar
• PIVARCSI A, NAGY I, KORECK A et al.: Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect. (2005) 7(9-10):1117-1127.
   PubMed Web of Science ®Google Scholar
• BERGMAN P, JOHANSSON L, ASP V et al.: Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. (2005) 7(7):1009-1017.
   PubMedGoogle Scholar
• OWEN SM, RUDOLPH DL, WANG W et al.: RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses (2004) 20(11):1157-1165.
   PubMed Web of Science ®Google Scholar
• VANCOMPERNOLLE SE, TAYLOR RJ, OSWALD-RICHTER K et al.: Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. J. Virol. (2005) 79(18):11598-11606.
   PubMedGoogle Scholar
• LORIN C, SAIDI H, BELAID A et al.: The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology (2005) 334(2):264-275.
   PubMed Web of Science ®Google Scholar
• LUSHBAUGH WB, BLOSSOM AC, SHAH PH et al.: Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice. Am. J. Trop. Med. Hyg. (2000) 63(5-6):284-289.
   PubMedGoogle Scholar
• OPPENHEIM JJ, YANG D: Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. (2005) 17(4):359-365.
   PubMed Web of Science ®Google Scholar
• DELFINO D, CUSUMANO VV, TOMASELLO F, CUSUMANO V: Beneficial effects of antibacterial peptide PR-39 in a neonatal murine model of endotoxic shock. New Microbiol. (2004) 27(4):369-374.
   PubMedGoogle Scholar
• KUROSAKA K, CHEN Q, YAROVINSKY F, OPPENHEIM JJ, YANG D: Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. (2005) 174(10):6257-6265.
   PubMed Web of Science ®Google Scholar
• DAVIDSON DJ, CURRIE AJ, REID GS et al.: The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. (2004) 172(2):1146-1156.
   PubMed Web of Science ®Google Scholar
• SHAYKHIEV R, BEISSWENGER C, KANDLER K et al.: Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell Mol. Physiol. (2005) 289(5):L842-L848.
   PubMed Web of Science ®Google Scholar
• BRAFF MH, HAWKINS MA, DI NARDO A et al.: Structure–function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. (2005) 174(7):4271-4278.
   PubMed Web of Science ®Google Scholar
• CHAVAKIS T, CINES DB, RHEE JS et al.: Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J. (2004) 18(11):1306-1308.
   PubMed Web of Science ®Google Scholar
• LEE PH, RUDISILL JA, LIN KH et al.: HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair Regen. (2004) 12(3):351-358.
   PubMedGoogle Scholar
• VARADHACHARY A, WOLF JS, PETRAK K et al.: Oral lactoferrin inhibits growth of established tumours and potentiates conventional chemotherapy. Int. J. Cancer (2004) 111(3):398-403.
   PubMed Web of Science ®Google Scholar
• HAYES TG, FALCHOOK GF, VARADHACHARY GR et al.: Phase I trial of oral talactoferrin alfa in refractory solid tumours. Invest. New Drugs (2005) (In Press).
   Google Scholar
• BROUWER CPJ BS, WELLING MM, VELDERS MP, NIBBERING PH The high effective antimicrobial peptide hLF (1-11) may be given to (immunocompromised) mice with a multi-drug resistant Staphylococcus aureus infection by various routes. 45th Interscience Conference on Antimicrob. Agents Chemother. Washington DC, USA (2005).
   Google Scholar
• DING B, YIN N, LIU Y et al.: Origins of cell selectivity of cationic steroid antibiotics. J. Am. Chem. Soc. (2004) 126(42):13642-13648.
   PubMed Web of Science ®Google Scholar
• KICHLER A, LEBORGNE C, SAVAGE PB, DANOS O: Cationic steroid antibiotics demonstrate DNA delivery properties. J. Control Release (2005) 107(1):174-182.
   PubMed Web of Science ®Google Scholar
• ZASLOFF M: Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA (1987) 84(15):5449-5453.
   PubMed Web of Science ®Google Scholar
• BOWDISH DM, DAVIDSON DJ, LAU YE et al.: Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. (2005) 77(4):451-459.
   PubMed Web of Science ®Google Scholar
• YANG N, STROM MB, MEKONNEN SM, SVENDSEN JS, REKDAL O: The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. J. Pept. Sci. (2004) 10(1):37-46.
   PubMed Web of Science ®Google Scholar
• WASILUK KR, LESLIE DB, VIETZEN PS, MAYO KH, DUNN DL: Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein. Surgery (2004) 136(2):253-260.
   PubMedGoogle Scholar
• UKNIS ME, WASILUK KR, ACTON RD et al.: Design of a potent novel endotoxin antagonist. Surgery (1997) 122(2):380-385.
   Google Scholar
• VAN DER SCHAFT DW, TOEBES EA, HASEMAN JR, MAYO KH, GRIFFIOEN AW: Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood (2000) 96(1):176-181.
   Google Scholar
• TEW GN, LIU D, CHEN B et al.: De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. USA (2002) 99(8):5110-5114.
   PubMed Web of Science ®Google Scholar
• GRIECO P, ROSSI C, COLOMBO G et al.: Novel α-melanocyte stimulating hormone peptide analogues with high candidacidal activity. J. Med. Chem. (2003) 46(5):850-855.
   PubMedGoogle Scholar
• CATANIA A, GAROFALO L, CUTULI M et al.: Melanocortin peptides inhibit production of pro-inflammatory cytokines in blood of HIV-infected patients. Peptides (1998) 19(6):1099-1104.
   PubMedGoogle Scholar